Bayer (BAYRY) announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback